IBM Watson Health, Cota and Hackensack Meridian Health have joined together to help oncologists make evidence- and outcomes-based clinical decisions for their cancer patients, which could reduce total cost of care.
IBM Watson Health
Advertisement
Articles by IBM Watson Health
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer
2
FDA Approves Maintenance Tucatinib for Advanced HER2+ Breast Cancer
3
IMS 2026: Beth Faiman Talks New Definition of Myeloma Cure and More
4
Surveillance, Patient Resources, and Financial Support
5